Messenger RNA technology allows changing the vaccine strains relatively faster, and Pfizer expects this flexibility and its rapid manufacturing to potentially allow better strain matches in future years.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/ogftl9w
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Pfizer starts late-stage trial of mRNA-based flu vaccine
https://ift.tt/wM7gq1e
No comments:
Post a Comment